Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 2
2013 1
2014 2
2015 3
2016 1
2018 6
2019 3
2020 5
2021 6
2022 6
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacokinetics and Pharmacodynamic of Alpelisib.
Royer B, Kaderbhaï CG, Schmitt A. Royer B, et al. Among authors: schmitt a. Clin Pharmacokinet. 2023 Jan;62(1):45-53. doi: 10.1007/s40262-022-01195-2. Epub 2023 Jan 12. Clin Pharmacokinet. 2023. PMID: 36633813 Review.
Trastuzumab-emtansine induced pleural and pericardial effusions.
Lombardi J, Lory P, Martin N, Mayeur D, Combret S, Grandvuillemin A, Boulay C, Schmitt A. Lombardi J, et al. Among authors: schmitt a. J Oncol Pharm Pract. 2021 Dec;27(8):2041-2044. doi: 10.1177/10781552211015772. Epub 2021 May 18. J Oncol Pharm Pract. 2021. PMID: 34000917
How can we best monitor 5-FU administration to maximize benefit to risk ratio?
Goirand F, Lemaitre F, Launay M, Tron C, Chatelut E, Boyer JC, Bardou M, Schmitt A. Goirand F, et al. Among authors: schmitt a. Expert Opin Drug Metab Toxicol. 2018 Dec;14(12):1303-1313. doi: 10.1080/17425255.2018.1550484. Epub 2018 Nov 23. Expert Opin Drug Metab Toxicol. 2018. PMID: 30451549 Free article. Review.
Population Pharmacokinetics of Palbociclib in aReal-World Situation.
Royer B, Kaderbhaï C, Fumet JD, Hennequin A, Desmoulins I, Ladoire S, Ayati S, Mayeur D, Ilie S, Schmitt A. Royer B, et al. Among authors: schmitt a. Pharmaceuticals (Basel). 2021 Feb 24;14(3):181. doi: 10.3390/ph14030181. Pharmaceuticals (Basel). 2021. PMID: 33668400 Free PMC article.
Exposure-response analysis of Raltitrexed assessing liver toxicity.
Royer B, Schmitt A, Nguyen T, Paillard MJ, Jary M, Demarchi M, Vernerey D, Henriques J, Jacquin M, Borg C, Kim S. Royer B, et al. Among authors: schmitt a. Br J Clin Pharmacol. 2021 Mar;87(3):1327-1337. doi: 10.1111/bcp.14519. Epub 2020 Sep 4. Br J Clin Pharmacol. 2021. PMID: 32789966 Free article. Clinical Trial.
[Practical management of PARP inhibitors: A French DELPHI consensus].
Selle F, Boffa JJ, Etienne G, Angelergues A, Augereau P, Berton D, Dielenseger P, Fabbro M, Falandry C, Follana P, Gladieff L, Joly F, Kurtz JE, Matta C, Mouret-Reynier MA, Schmitt A, Scotté F, Marjollet C, Floquet A. Selle F, et al. Among authors: schmitt a. Bull Cancer. 2022 Dec;109(12):1245-1261. doi: 10.1016/j.bulcan.2022.06.011. Epub 2022 Sep 13. Bull Cancer. 2022. PMID: 36109248 Free article. French.
Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach.
Reda M, Macaire P, Bellio H, Uwer L, Ilie S, Lorgis V, Hennequin A, Ladoire S, Rederstorff E, Fumoleau P, Isambert N, Bonnin N, You B, Freyer G, Desmoulins I, Schmitt A. Reda M, et al. Among authors: schmitt a. Cancer Chemother Pharmacol. 2022 Feb;89(2):197-208. doi: 10.1007/s00280-021-04395-y. Epub 2022 Jan 8. Cancer Chemother Pharmacol. 2022. PMID: 34997290
35 results